Naproxen Emo Bausch Health Ireland Limited

Naproxen, the active ingredient in Naproxen Emo, is a nonsteroidal anti-inflammatory drug presented as a topical formulation for cutaneous use. It treats mild to moderate pain and inflammation associated with musculoskeletal conditions. GNH USA supplies Naproxen Emo as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen Emo is an NSAID that reduces inflammation and pain in musculoskeletal disorders.

- Mild to moderate pain: provides analgesic relief for everyday aches. - Musculoskeletal inflammation: decreases swelling and discomfort in joints and muscles. - Localized joint or muscle pain: offers targeted topical treatment for specific areas.

Naproxen Emo may cause adverse skin reactions and systemic effects, although they are generally uncommon.

Common Side Effects: - Skin irritation: redness, itching, or burning at the application site. - Dryness: localized dryness or flaking of the skin. - Mild rash: transient erythematous rash.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Contact dermatitis: persistent inflammation requiring medical attention. - Systemic NSAID effects: rare gastrointestinal upset if absorbed in significant amounts.

Before using Naproxen Emo, consider the following safety measures.

- Skin integrity: avoid application on broken or infected skin. - Allergy history: do not use if you have known hypersensitivity to naproxen or other NSAIDs. - Concurrent NSAIDs: limit use of other NSAIDs to reduce risk of additive toxicity. - Pregnancy and lactation: consult a healthcare professional before use. - Elderly patients: monitor closely for skin reactions. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Naproxen Emo can interact with other medicines, especially those affecting bleeding or renal function.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other topical NSAIDs: cumulative local toxicity.

Moderate Interactions (Monitor Closely): - Systemic NSAIDs: heightened gastrointestinal and renal adverse effects. - ACE inhibitors or diuretics: possible reduction in renal perfusion. - Lithium: potential increase in lithium levels.